Fulcare Pharmaceutical Private Limited
About Fulcare Pharmaceutical Private Limited
Data last updated:
Fulcare Pharmaceutical Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U36999GJ2018PTC100562. Its GSTIN is 24AADCF2908A1ZB (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhagvatilal Shantilal Inani and Sunitaben Bhagvatilal Inani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 12 Basant Bahar Apartment B/H Rajasthan Hospital Shahibaug, Ahmedabad, Gujarat, India – 380004.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.76 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹11,647 (net margin 0.4%) and EBITDA of ₹50,149 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fulcare Pharmaceutical Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressA – 12 Basant Bahar Apartment B/H Rajasthan Hospital Shahibaug, Ahmedabad, Gujarat, India – 380004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fulcare Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fulcare Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fulcare Pharmaceutical Private Limited, buy the company report.
Financials of Fulcare Pharmaceutical Private Limited
FY 2025 filings availableFulcare Pharmaceutical Private Limited reported revenue of ₹27.76 Lakh (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 6% growth in the latest year. EBITDA rose 212% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,149 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,647 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fulcare Pharmaceutical Private Limited, buy the company report.
Board of directors of Fulcare Pharmaceutical Private Limited
Fulcare Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagvatilal Shantilal Inani Also directs: Sabwell Pharmaceuticals Private Limited | Director | 07 Jun 2019 | 7 Years 5 Months | Current |
| Sunitaben Bhagvatilal Inani | Director | 16 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Fulcare Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MTD Marketing Private Limited | ₹27.76 Lakh (FY 2022) | -94.0% | Howrah, West Bengal, India | |||
| Zoh Farms Private Limited | ₹27.76 Lakh (FY 2024) | 5588.0% | Mumbai, Maharashtra, India | |||
| Nexxgen Ispat Private Limited | ₹27.76 Lakh (FY 2025) | -83.0% | Ranchi, Jharkhand, India | |||
| Keshvanand Chemicals Pvt Ltd. | ₹27.76 Lakh (FY 2025) | -75.0% | Gwalior, Madhya Pradesh, India | |||
| Alps Vyapar Private Limited | ₹27.76 Lakh (FY 2025) | -4.0% | Kolkata, West Bengal, India | |||
| Fulcare Pharmaceutical Private Limitedthis company | ₹27.76 Lakh (FY 2024) | ₹11,647 | 0.4% | 6.0% | Ahmedabad, Gujarat, India | |
| Lune Realcon Private Limited | ₹27.76 Lakh (FY 2018) | -19.0% | Kolkata, West Bengal, India | |||
| Xempt Designs Private Limited | ₹27.75 Lakh (FY 2018) | -46.0% | Jaipur, Rajasthan, India | |||
| Greenkashi Bio Energy Private Limited | ₹27.75 Lakh (FY 2024) | -90.0% | Chunar, Uttar Pradesh, India | |||
| Erinley Biotec Private Limited | ₹27.75 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| JDK Associates India Private Limited | ₹27.74 Lakh (FY 2015) | -10.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Fulcare Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Sep 2023 | 100788622 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Fulcare Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fulcare Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fulcare Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCF2908A1ZB | Gujarat | Active | 29 Jan 2018 |
To see the full GST registrations and return filing status of Fulcare Pharmaceutical Private Limited, buy the company report.
Recent activity
Fulcare Pharmaceutical Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Harishbhai Manubhai Solanki ceased to be Additional Director on 01 Oct 2020.
Frequently asked questions
Fulcare Pharmaceutical is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2018 (8+ years old) and is registered under CIN U36999GJ2018PTC100562.
Fulcare Pharmaceutical has 2 current directors:
- Bhagvatilal Shantilal Inani - Director
- Sunitaben Bhagvatilal Inani - Director
The latest financial statements of Fulcare Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Fulcare Pharmaceutical is 24AADCF2908A1ZB, registered in Gujarat.
The CIN (Corporate Identification Number) of Fulcare Pharmaceutical is U36999GJ2018PTC100562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fulcare Pharmaceutical was incorporated on 16 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Fulcare Pharmaceutical by revenue are MTD Marketing Private Limited, Zoh Farms Private Limited, Nexxgen Ispat Private Limited, Keshvanand Chemicals Pvt Ltd, Alps Vyapar Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Harishbhai Manubhai Solanki ceased to be Additional Director on 01 Oct 2020. Ila Himanshu Parekh ceased to be Additional Director on 01 Oct 2020. Ranjeeta Rajesh Kandavar ceased to be Additional Director on 01 Oct 2020. Fulcare Pharmaceutical has 7 board changes on record in total.
The registered office of Fulcare Pharmaceutical is at A – 12 Basant Bahar Apartment BH Rajasthan Hospital Shahibaug, Ahmedabad, Gujarat, India – 380004.
Fulcare Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Fulcare Pharmaceutical has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
